Placebo-controlled biofeedback blood pressure effect in hypertensive humans

Hypertension

Volumn 29, Issue 6, 1997, Pages 1225-1231

  Hunyor, Stephen N ^a,b   Henderson, Robyn J ^a   Lal, Saroj K L ^a   Carter, Norman L ^c   Kobler, Henry ^a   Jones, Michael ^a   Bartrop, Roger W ^b   Craig, Ashley ^d   Mihailidou, Anastasia S ^a  

^a Cardiovascular Research Unit   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c NATIONAL ACOUSTIC LABORATORIES   (Australia)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

biofeedback; blood pressure monitoring; placebo effect

Indexed keywords

PLACEBO;

ADULT; ARTICLE; AUTONOMIC INNERVATION; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEEDBACK SYSTEM; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY BLOOD FLOW; MAJOR CLINICAL STUDY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING;

EID: 0030974394     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.6.1225     Document Type: Article

References (43)

1. Stokes J III, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease: The Framingham Study - 30 years of follow-up. Hypertension. 1989; 13(suppl I):I-13-I-18.
2. Schappert SM. National Ambulatory Medical Care Survey: 1991 Summary. US Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, Md. Vital Health Stat. 1994;13:1-110.
3. Hunyor SN, Henderson RJ. The role of stress management in blood pressure control: why the promissory note has failed to deliver. J Hypertens. 1996;14:413-418.
4. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Ebertein KA. Blood pressure, stroke and coronary heart disease, Part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
5. Multiple Risk Factor Intervention Trial Research Group. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1985;55:1-15.
6. Klein LE. Compliance and blood pressure control. Hypertension. 1988;11:1161-1164.
7. Panfilov VV, Reid JL. Brain and autonomie mechanisms in hypertension. J Hypertens. 1994;12:337-343.
8. Esler M, Ferrier C, Lambert G, Eiseindorfer G, Cox H, Jennings G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension. 1991;17(suppl III):III-29-III-35.
9. Julius S. Autonomie nervous system dysregulation in human hypertension. Am J Cardiol. 1991;67:3B-7B.
10. Folkow B, Hallback M, Lundgren Y, Sivertsson R, Weiss H. Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats. Circ Res. 1973;32(suppl I):I-2-I-16.
11. Chalmers JP, Pilowsky PM. Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. J Hypertens. 1991; 9:675-694.
12. Wallin BG, Sundlof G, Stromgren E, Aberg H. Sympathetic outflow to muscles during treatment of hypertension with metoprolol. Hypertension. 1984;6:557-562.
13. Littler WA, Honour AJ, Carter RD, Sleight P. Sleep and blood pressure. Br Med J. 1975;3:346-348.
14. Henry JP, Cassel JC. Psychosocial factors in essential hypertension: epidemiologic and animal experimental evidence. Am J Epidemiol. 1969;90:171-180.
15. Miller NE, DiCara LV. Instrumental learning of peripheral vasomotor responses by the curarised rat. Am J Physiol. 1968;215: 677-683.
16. Snyder C, Noble M. Operant conditioning of vasoconstriction. J Exp Psychol. 1968;77:263-268.
17. Health and Public Policy Committee. American College of Physicians. Biofeedback for hypertension. Ann Intern Med. 1985;102:709-715.
18. Messerli FH, De Carvalho JGR, Christie B, Frohlich ED. Systemic haemodynamic effects of biofeedback in borderline hypertension. Clin Sci. 1979;57(suppl):437s-439s.
19. Sackett DL, Haynes RB, Tugwell P. Clinical Epidemiology. A Basic Science for Clinical Medicine. Boston, Mass: Little, Brown & Co; 1985.
20. Jacob RG, Fortmann SP, Kraemer HL, Farquhar JW, Agras WW. Combining behavioral treatments to reduce blood pressure: a controlled outcome study. Behav Modif. 1985;9:32-53.
21. Eisenberg DM, Delbanco TL, Berkey CS, Kaptchuk TJ, Kupelnick B, Kuhl J, Chalmers TC. Cognitive behavioral techniques for hypertension: are they effective? Ann Intern Med. 1993;118:964-972.
22. Lal SKL, Henderson RJ, Cejnar M, Hart MG, Hunyor SN. Physiological influences on continuous finger and simultaneous intra-arterial blood pressure. Hypertension. 1995;26:307-314.
23. Cejnar M, Hunyor SN, Liggins GW, Bartrop R. Voluntary blood pressure control using continuous systolic blood pressure biofeedback. Clin Exp Pharmacol Physiol. 1988;15:265-269.
24. Penaz J. Photoelectric measurement of blood pressure volume and flow in the finger. In: Digest of the 10th International Conference on Medical and Biological Engineering. Dresden, FRG: International Federation for Medical and Biological Engineering; 1973:104.
25. Kobler H, Cejnar M, Hunyor SN. A continuous non-invasive blood pressure monitor. J Electric Electron Eng Aust. 1991;11:102-108.
26. Sherrick CE. Basic and applied research on tactile aids for deaf people: progress and prospects. J Acoust Soc Am. 1984;75:1325-1342.
27. Kelly JJ, Hunyor SN, Ho KY. Evaluation of the reproducibility and accuracy of ambulatory blood pressure monitoring using the Takeda TM-2420 automated blood pressure monitor. Clin Exp Hypertens. 1993;15:271-287.
28. Shah BV, Barnwell BG, Bieler GS. SUDAAN Users Manual: Software for Analysis of Correlated Data. Research Triangle Park, NC: Research Triangle Institute; 1995.
29. Ekman P. Methods for measuring facial action. In: Scherer KR, Ekman P, eds. Handbook of Methods in Nonverbal Behavior Research. New York, NY: Cambridge University Press; 1982:25-90.
30. Furedy JJ, Shulhan D. Specific versus placebo effects in biofeedback: some brief back-to-basic considerations. Biofeedback Self Regul. 1987; 12:211-215.
31. Sawada Y, Yamakoshi K-I. A preliminary study of beat-to-beat blood pressure biofeedback using the vascular unloading method. Jpn Psychol Res. 1991;33:42-47.
32. Hatch JP, Klatt K, Fitzgerald M, Jasheway LS, Fisher JG. Cognitive and physiologic responses to EMG biofeedback and three types of pseudofeedback during a muscular relaxation task. Biofeedback Self Regul. 1983;8:409-425.
33. Goebel M, Viol GW, Orebaugh C. An incremental model to isolate specific effects of behavioral treatments in essential hypertension. Biofeedback Self Regul. 1993;18:255-280.
34. Kotses H, Glaus KD, Crawford PL, Edwards JE, Sherr MS. Operant reduction of frontalis EMG activity in the treatment of asthma in children. J Psychosom Res. 1976;20:453-459.
35. Patel C, Marmot MG, Terry DJ. Controlled trial of biofeedback-aided behavioural methods in reducing mild hypertension. Br Med J. 1981; 282:2005-2008.
36. Carlson JG, Feld JL. Expectancies of reinforcement control in biofeedback and cognitive performance. Biofeedback Self Regul. 1981;6:79-91.
37. Brown WA. Placebo as a treatment for depression. Neuropsychopharmacology. 1994;10:265-269.
38. On practise, practice, and praxis. Lancet. 1993;342:1002-1003. Editorial.
39. Hebb DO. Organization of Behavior. New York, NY: John Wiley & Sons Inc; 1964.
40. Treisman A, Gormican S. Feature analysis in early vision: evidence from search asymmetries. Psychol Rev. 1988;95:15-48.
41. Julesz B. Early vision is bottom-up, except for focal attention. Cold Spring Harbor Symposium on Quantitative Biology. The Brain. 1990;55:973-978.
42. Spitzer H, Desimone R, Moran J. Increased attention enhances both behavioral and neuronal performance. Science. 1988;240:338-340.
43. Robinson DL, Petersen SE. The pulvinar and visual salience. Trends Neurosci. 1992;15:127-132.